Green Cross, Daewoong Diverge In Global Expansion Push

Two leading South Korean pharma firms are moving in different directions as they aim to expand globally, with Daewoong Pharm agreeing to buy a controlling stake in HanAll BioPharma, while Green Cross has divested its entire stake in Ildong Pharm.

SEOUL – Although the two companies seem to have different strategies, the ultimate purpose is the same: to focus on and accelerate expansion of their global businesses.

Daewoong Pharmaceutical Co. Ltd. said it will buy a 30.2% stake, equivalent to 15.5 million shares, in smaller rival...

More from South Korea

More from Focus On Asia